EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Gradual Transition Toward Anaplasia in Wilms Tumor Through Tolerance to Genetic Damage

Kaname Uno, Bahar Rastegar, Caroline Jansson, Geoffroy Durand, Anders Valind, Subhayan Chattopadhyay, Alessia Bertolotti, Sara Ciceri, Filippo Spreafico, Paola Collini, Daniela Perotti, Linda Holmquist Mengelbier und 1 weitere

Modern Pathology · 2024-01 · 37 (1) · 100382

DOI: 10.1016/j.modpat.2023.100382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2024-01. Verfasst von Kaname Uno und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden; Department of Obstetrics and Gynecology, Nagoya Univ…. Hauptthemen laut MEDLINE: Kidney Neoplasms, Wilms Tumor. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Royal Physiographic Society of Lund, Lunds University Faculty of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with Wilms tumor (WT) in general have excellent survival, but the prognosis of patients belonging to the subgroup of WT with diffuse anaplasia (DA) is poor due to frequent resistance to chemotherapy. We hypothesized that DA WT cells might undergo changes, such as acquiring a persistent tolerance to DNA damage and copy number aberrations (CNAs), which could eventually lead to their resistance to chemotherapy treatment. Tissue sections from chemotherapy-treated DA WTs (n = 12) were compared with chemotherapy-treated nonanaplastic WTs (n = 15) in a tissue microarray system, enabling analysis of 769 tumor regions. All regions were scored for anaplastic features and immunohistochemistry was used to quantify p53 expression, proliferation index (Ki67), and DNA double-strand breaks (γH2AX). CNAs were assessed by array-based genotyping and TP53 mutations using targeted sequencing. Proliferation index and the frequency of DNA double-strand breaks (γH2AX dot expression) increased with higher anaplasia scores. Almost all (95.6%) areas with full-scale anaplasia had TP53 mutations or loss of heterozygosity, along with an increased amount of CNAs. Interestingly, areas with wild-type TP53 with loss of heterozygosity and only one feature of anaplasia (anaplasia score 1) also had significantly higher proliferation indices, more DNA double-strand breaks, and more CNAs than regions without any anaplastic features (score 0); such areas may be preanaplastic cell populations under selective pressure for TP53 mutations. In conclusion, we suggest that chemoresistance of DA WTs may be partly explained by a high proliferative capability of anaplastic cells, which also have a high burden of double-stranded DNA breaks and CNAs, and that there is a gradual emergence of anaplasia in WT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney NeoplasmsWilms TumorHumansAnaplasiaMutationPrognosisDNA

Stichwörter der Autor:innen

TP53 mutation/loss of heterozygosity (LOH)Wilms tumoranaplasiacopy number aberrationsdouble-stranded DNA breaks

Substanzen

DNA

Autor:innen und Institutionen

  • Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden; Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address:…
  • Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden; Now with Childhood Cancer Center, Skåne University Hospital, Lund, Sweden.
  • Diagnostic and Molecular Research Lab, Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Molecular Bases of Genetic Risk and Genetic Testing Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Now with Predictive Medicine: Molecular Bases of Genetic Risk,…
  • Pediatric Oncology Unit, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Förderung

  • Swedish Research Council
  • Royal Physiographic Society of Lund
  • Lunds University Faculty of Medicine
  • Swedish Cancer Society

Zitieren

APA

Uno, K., Rastegar, B., Jansson, C., Durand, G., Valind, A., Chattopadhyay, S., Bertolotti, A., Ciceri, S., Spreafico, F., Collini, P., Perotti, D., Mengelbier, L. H., & Gisselsson, D. (2024). A Gradual Transition Toward Anaplasia in Wilms Tumor Through Tolerance to Genetic Damage. Modern Pathology, 37(1), 100382. https://doi.org/10.1016/j.modpat.2023.100382

Vancouver

Uno K, Rastegar B, Jansson C, Durand G, Valind A, Chattopadhyay S, et al. A Gradual Transition Toward Anaplasia in Wilms Tumor Through Tolerance to Genetic Damage. Modern Pathology. 2024;37(1):100382. doi:10.1016/j.modpat.2023.100382

BibTeX
@article{Uno2024,
  author = {Uno, Kaname and Rastegar, Bahar and Jansson, Caroline and Durand, Geoffroy and Valind, Anders and Chattopadhyay, Subhayan and Bertolotti, Alessia and Ciceri, Sara and Spreafico, Filippo and Collini, Paola and Perotti, Daniela and Mengelbier, Linda Holmquist and Gisselsson, David},
  title = {A Gradual Transition Toward Anaplasia in Wilms Tumor Through Tolerance to Genetic Damage},
  journal = {Modern Pathology},
  year = {2024},
  volume = {37},
  number = {1},
  pages = {100382},
  doi = {10.1016/j.modpat.2023.100382}
}
Kostenlos starten →